title: [Current perspectives in the treatment of Parkinson disease].
authors.forename: M
authors.initials: M
authors.lastname: Rodríguez
authors.forename: M D
authors.initials: MD
authors.lastname: Palarea
authors.forename: R
authors.initials: R
authors.lastname: Castro
authors.forename: J
authors.initials: J
authors.lastname: Pérez
authors.forename: R
authors.initials: R
authors.lastname: Arévalo
mesh_terms: D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D001923:Brain Chemistry; D004298:Dopamine / Q000378:metabolism / Q000502:physiology; D018492:Dopamine Antagonists; D006801:Humans; D007980:Levodopa / Q000627:therapeutic use; D018377:Neurotransmitter Agents / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy* / Q000503:physiopathology; D009435:Synaptic Transmission; D014446:Tyrosine 3-Monooxygenase / Q000378:metabolism
chemical_list: D018492:Dopamine Antagonists; D018377:Neurotransmitter Agents; D001708:Biopterins; D007980:Levodopa; D014446:Tyrosine 3-Monooxygenase; C003402:sapropterin; D004298:Dopamine
vernacular_title: Perspectivas actuales en el tratamiento de la enfermedad de Parkinson.